Globus Medical, Inc. GMED
Set alert
At close · Oct 30
After hours · Oct 30, 4:33 PM ET
- YTD
- -10.61%
- 1 year
- +28.54%
- Open
- 80.80
- Prev close
- 82.91
- Mkt cap
- 10.48B
- Vol
- 1.68M
- Avg vol
- 1.40M
- EPS
- 3.90
- P/E
- 20.01
- Div yield
- 0.00%
More statistics
- Low
- 77.77
- High
- 80.84
- Forward P/E
- 14.49
- Beta
- 0.96
- Short ratio
- 5.17
- Inst. own
- 94.12%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 77.77
- 200-d avg
- 83.57
- 1y target
- 100.92
2Y chart
Events in this range
- Aug 7, 2025Earnings: 0.86; estimate 0.76; surprise 13.16%
- Nov 6, 2025Earnings: 1.18; estimate 0.781; surprise 51.09%
- Feb 24, 2026Earnings: 1.28; estimate 1.06; surprise 20.75%
- May 7, 2026Earnings: 1.12; estimate 0.92; surprise 21.74%
- Jul 9, 2026Rating: BMO Capital · — → Outperform
- Jul 13, 2026Rating: RBC Capital · Outperform → Outperform
- Jul 16, 2026Rating: Truist Securities · Buy → Buy
- Jul 28, 2026Rating: UBS · — → Neutral
- Aug 6, 2026Earnings: 1.34; estimate 1.1; surprise 21.82%
- Aug 7, 2026Rating: Wells Fargo · Overweight → Overweight
- Oct 1, 2026Rating: RBC Capital · Outperform → Outperform
Signals (92)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| MACD: Buy Signal | Sep 25, 2026 | 1 month ago |
| RSI: Oversold | Sep 10, 2026 | 1 month ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 25, 2026 | 2 months ago |
| SMA: Bearish | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | Aug 18, 2026 | 2 months ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Jul 31, 2026 | 3 months ago |
| SMA: Bullish | Jul 28, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 27, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 20, 2026 | 3 months ago |
| SMA: Bearish | Jul 17, 2026 | 3 months ago |
| SMA: Bullish | Jul 16, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 16, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 8, 2026 | 3 months ago |
| SMA: Bearish | Jun 30, 2026 | 4 months ago |
| SMA: Bearish | Jun 30, 2026 | 4 months ago |
| SMA: Bullish | Jun 25, 2026 | 4 months ago |
| SMA: Bullish | Jun 24, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 22, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 17, 2026 | 4 months ago |
| SMA: Bearish | Jun 12, 2026 | 4 months ago |
| SMA: Bullish | Jun 9, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 4, 2026 | 5 months ago |
| MACD: Sell Signal | Jun 3, 2026 | 5 months ago |
| SMA: Bearish | Jun 2, 2026 | 5 months ago |
| MACD: Buy Signal | May 21, 2026 | 5 months ago |
| SMA: Bullish | May 18, 2026 | 5 months ago |
| RSI: Oversold | May 15, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| RSI: Oversold | May 8, 2026 | 5 months ago |
| SMA: Bearish | May 5, 2026 | 6 months ago |
| SMA: Bullish | Apr 30, 2026 | 6 months ago |
| SMA: Bearish | Apr 29, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 28, 2026 | 6 months ago |
| SMA: Bullish | Apr 7, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 1, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 27, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 26, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 5, 2026 | 8 months ago |
| SMA: Bearish | Mar 4, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 19, 2026 | 8 months ago |
| SMA: Bullish | Feb 18, 2026 | 8 months ago |
| SMA: Bearish | Feb 3, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 23, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 22, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 20, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 15, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 13, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 8, 2026 | 9 months ago |
| RSI: Overbought | Jan 6, 2026 | 9 months ago |
| RSI: Overbought | Dec 4, 2025 | 11 months ago |
| MACD: Sell Signal | Dec 3, 2025 | 11 months ago |
| SMA: Bullish | Nov 7, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 7, 2025 | 11 months ago |
| RSI: Overbought | Nov 7, 2025 | 11 months ago |
| MACD: Sell Signal | Oct 31, 2025 | 1 year ago |
| SMA: Bullish | Oct 17, 2025 | 1 year ago |
| SMA: Bearish | Oct 10, 2025 | 1 year ago |
| SMA: Bullish | Oct 1, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 1, 2025 | 1 year ago |
| SMA: Bearish | Sep 17, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 2, 2025 | 1 year ago |
| RSI: Overbought | Aug 13, 2025 | 1 year ago |
| SMA: Bullish | Aug 8, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 5, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 21, 2025 | 1 year ago |
| RSI: Oversold | Jul 21, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 17, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 15, 2025 | 1 year ago |
| MACD: Buy Signal | May 29, 2025 | 1 year ago |
| RSI: Oversold | May 15, 2025 | 1 year ago |
| MACD: Sell Signal | May 9, 2025 | 1 year ago |
| RSI: Oversold | May 9, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 9, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 8, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 20, 2025 | 1 year ago |
| RSI: Oversold | Mar 18, 2025 | 1 year ago |
| RSI: Oversold | Mar 10, 2025 | 1 year ago |
| RSI: Oversold | Mar 6, 2025 | 1 year ago |
| RSI: Oversold | Mar 4, 2025 | 1 year ago |
| RSI: Oversold | Feb 21, 2025 | 1 year ago |
| SMA: Bearish | Feb 11, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 4, 2025 | 1 year ago |
| RSI: Overbought | Jan 14, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 8, 2025 | 1 year ago |
| RSI: Overbought | Dec 3, 2024 | 1 year ago |
Key statistics
- Market cap
- 10.48B
- Enterprise value
- 10.65B
- Trailing P/E
- 20.02
- Forward P/E
- 14.49
- PEG ratio
- 1.49
- Price / sales
- 3.33
- Price / book
- 2.20
- EPS (TTM)
- 3.90
- Beta
- 0.96
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 17.03%
- Revenue (TTM)
- 3.14B
- Revenue growth
- 5.90%
- Free cash flow
- 554.19M
- Total cash
- 595.14M
- Total debt
- 111.91M
- Return on equity
- 11.81%
- Shares outstanding
- 111.83M
- Short % of float
- 7.38%
- 50-day average
- 77.77
- 200-day average
- 83.57
Analyst view
Consensus: buy
- Target (low)
- 84.00
- Target (mean)
- 100.92
- Target (high)
- 125.00
- Strong buy3
- Buy7
- Hold4
- Sell0
- Strong sell0
Next earnings
Nov 5, 2026
Expected Nov 5, 2026. Consensus EPS estimate 1.20.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2026 | Sep 30, 2026 | 1.20 | — | — | — |
| Aug 6, 2026 | Jun 30, 2026 | 1.10 | 1.34 | +0.24 | +21.82% |
| May 7, 2026 | Mar 31, 2026 | 0.92 | 1.12 | +0.20 | +21.74% |
| Feb 24, 2026 | Dec 31, 2025 | 1.06 | 1.28 | +0.22 | +20.75% |
| Nov 6, 2025 | Sep 30, 2025 | 0.781 | 1.18 | +0.40 | +51.09% |
| Aug 7, 2025 | Jun 30, 2025 | 0.76 | 0.86 | +0.10 | +13.16% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 1, 2026 | RBC Capital | main | Outperform | Outperform |
| Aug 7, 2026 | Wells Fargo | main | Overweight | Overweight |
| Jul 28, 2026 | UBS | init | — | Neutral |
| Jul 16, 2026 | Truist Securities | main | Buy | Buy |
| Jul 13, 2026 | RBC Capital | main | Outperform | Outperform |
| Jul 9, 2026 | BMO Capital | init | — | Outperform |
About Globus Medical, Inc.
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- globusmedical.com
News
- 2 Healthcare Technology Stocks for a Digital Health Boom
- Gibbs Wealth Management Purchases 7,829 Shares of Globus Medical, Inc. $GMED
- Kuehn Law Encourages Investors of Globus Medical, Inc. to Contact Law Firm
- Globus Medical (GMED) is a Top-Ranked Value Stock: Should You Buy?
- GMED or AXGN: Which Is the Better Value Stock Right Now?
- Globus Medical to Showcase SCRIPT™ Patient-Specific Implants and New XLIF™ Prone Procedural Solution at NASS 2026
- Globus Medical Schedules Third Quarter Earnings Release and Conference Call
- Globus Medical Q2 2026 Earnings Call Transcript
- Reasons to Add Globus Medical Stock to Your Portfolio Now
- Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific
Your note
Sign in to keep a note on GMED — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DAVIDAR DAVID D | Director | Stock Gift | Jul 26, 2026 | 673,642 |
| KLINE KYLE | Chief Financial Officer | Sale | Jan 7, 2026 | 0 |
| LEMAITRE DANIEL | Director | Sale | Nov 21, 2024 | 0 |
| NORWALK LESLIE V | Director | Sale | Jan 7, 2026 | 10,419 |
| PAUL DAVID C | Officer, Director and Beneficial Owner | Conversion of Exercise of derivative security | Dec 7, 2025 | 60,417 |
| PFEIL KEITH W. | Chief Operating Officer | Sale | Jan 9, 2025 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 8.05% | 10,806,724 | 843.90M | Jun 29, 2026 |
| Jupiter Topco LLC | 6.11% | 8,200,423 | 640.37M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 3.80% | 5,107,532 | 398.85M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 3.72% | 4,994,385 | 390.01M | Jun 29, 2026 |
| Invesco Ltd. | 3.21% | 4,309,771 | 336.55M | Jun 29, 2026 |
| Kayne Anderson Rudnick Investment Management LLC | 3.19% | 4,279,730 | 334.20M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 2.97% | 3,983,485 | 311.07M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.68% | 3,595,564 | 280.78M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.93% | 2,597,815 | 202.86M | Jun 29, 2026 |
| JANUS INVESTMENT FUND-Janus Henderson Enterprise Fund | 1.64% | 2,207,141 | 172.36M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.11% | 1,496,500 | 116.86M | Jun 29, 2026 |
| J.P. Morgan Fleming Mutual Fd. Group, Inc.-JPMorgan Mid Cap Value Fd. | 1.10% | 1,475,978 | 115.26M | Jun 29, 2026 |